Načítá se...
Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
Direct-to-consumer genetic tests (DTC-GT) have become a bridge between marketing and traditional healthcare services. After earning FDA endorsement for such facilities, several fast-developing companies started to compete in the related area. Pharmacogenomic (PGx) tests have been introduced as poten...
Uloženo v:
| Vydáno v: | Genes (Basel) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7999840/ https://ncbi.nlm.nih.gov/pubmed/33802585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12030361 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|